197 related articles for article (PubMed ID: 8384139)
1. Quinolone action in Escherichia coli cells carrying gyrA and gyrB mutations.
Herrera G; Aleixandra V; Urios A; Blanco M
FEMS Microbiol Lett; 1993 Jan; 106(2):187-91. PubMed ID: 8384139
[TBL] [Abstract][Full Text] [Related]
2. New Escherichia coli gyrA and gyrB mutations which have a graded effect on DNA supercoiling.
Aleixandre V; Urios A; Herrera G; Blanco M
Mol Gen Genet; 1989 Oct; 219(1-2):306-12. PubMed ID: 2559316
[TBL] [Abstract][Full Text] [Related]
3. Detection of mutations in the gyrA and parC genes in quinolone-resistant clinical isolates of Enterobacter cloacae.
Deguchi T; Yasuda M; Nakano M; Ozeki S; Kanematsu E; Nishino Y; Ishihara S; Kawada Y
J Antimicrob Chemother; 1997 Oct; 40(4):543-9. PubMed ID: 9372424
[TBL] [Abstract][Full Text] [Related]
4. Ciprofloxacin and the fluoroquinolones. New concepts on the mechanism of action and resistance.
Fisher LM; Lawrence JM; Josty IC; Hopewell R; Margerrison EE; Cullen ME
Am J Med; 1989 Nov; 87(5A):2S-8S. PubMed ID: 2574005
[TBL] [Abstract][Full Text] [Related]
5. Detection of gyrA and gyrB mutations in quinolone-resistant clinical isolates of Escherichia coli by single-strand conformational polymorphism analysis and determination of levels of resistance conferred by two different single gyrA mutations.
Ouabdesselam S; Hooper DC; Tankovic J; Soussy CJ
Antimicrob Agents Chemother; 1995 Aug; 39(8):1667-70. PubMed ID: 7486897
[TBL] [Abstract][Full Text] [Related]
6. Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.
Ito H; Yoshida H; Bogaki-Shonai M; Niga T; Hattori H; Nakamura S
Antimicrob Agents Chemother; 1994 Sep; 38(9):2014-23. PubMed ID: 7811012
[TBL] [Abstract][Full Text] [Related]
7. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli.
Yoshida H; Bogaki M; Nakamura M; Nakamura S
Antimicrob Agents Chemother; 1990 Jun; 34(6):1271-2. PubMed ID: 2168148
[TBL] [Abstract][Full Text] [Related]
8. Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli.
Bagel S; Hüllen V; Wiedemann B; Heisig P
Antimicrob Agents Chemother; 1999 Apr; 43(4):868-75. PubMed ID: 10103193
[TBL] [Abstract][Full Text] [Related]
9. A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.
Truong QC; Nguyen Van JC; Shlaes D; Gutmann L; Moreau NJ
Antimicrob Agents Chemother; 1997 Jan; 41(1):85-90. PubMed ID: 8980760
[TBL] [Abstract][Full Text] [Related]
10. Development of a rapid assay for detecting gyrA mutations in Escherichia coli and determination of incidence of gyrA mutations in clinical strains isolated from patients with complicated urinary tract infections.
Ozeki S; Deguchi T; Yasuda M; Nakano M; Kawamura T; Nishino Y; Kawada Y
J Clin Microbiol; 1997 Sep; 35(9):2315-9. PubMed ID: 9276409
[TBL] [Abstract][Full Text] [Related]
11. Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Howard BM; Pinney RJ; Smith JT
Microbios; 1994; 77(311):121-31. PubMed ID: 8152392
[TBL] [Abstract][Full Text] [Related]
12. Quinolone mode of action--new aspects.
Hooper DC
Drugs; 1993; 45 Suppl 3():8-14. PubMed ID: 7689456
[TBL] [Abstract][Full Text] [Related]
13. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
14. Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene.
Kumagai Y; Kato JI; Hoshino K; Akasaka T; Sato K; Ikeda H
Antimicrob Agents Chemother; 1996 Mar; 40(3):710-14. PubMed ID: 8851598
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of action of and resistance to ciprofloxacin.
Hooper DC; Wolfson JS; Ng EY; Swartz MN
Am J Med; 1987 Apr; 82(4A):12-20. PubMed ID: 3034057
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA.
Masecar BL; Robillard NJ
Antimicrob Agents Chemother; 1991 May; 35(5):898-902. PubMed ID: 1649573
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the NH2-terminal 87th amino acid of Escherichia coli GyrA in quinolone-resistance.
Yonezawa M; Takahata M; Banzawa N; Matsubara N; Watanabe Y; Narita H
Microbiol Immunol; 1995; 39(7):517-20. PubMed ID: 8569537
[TBL] [Abstract][Full Text] [Related]
18. Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.
Cambau E; Bordon F; Collatz E; Gutmann L
Antimicrob Agents Chemother; 1993 Jun; 37(6):1247-52. PubMed ID: 8392306
[TBL] [Abstract][Full Text] [Related]
19. gyrA mutations in high-level fluoroquinolone-resistant clinical isolates of Escherichia coli.
Conrad S; Oethinger M; Kaifel K; Klotz G; Marre R; Kern WV
J Antimicrob Chemother; 1996 Sep; 38(3):443-55. PubMed ID: 8889719
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of gyrA Mutations in Nalidixic Acid-Resistant Strains of Salmonella Enteritidis Isolated from Humans, Food, Chickens, and the Farm Environment in Brazil.
Campioni F; Souza RA; Martins VV; Stehling EG; Bergamini AMM; Falcão JP
Microb Drug Resist; 2017 Jun; 23(4):421-428. PubMed ID: 27559761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]